Ronald Smulders

1.4k total citations
36 papers, 1.1k citations indexed

About

Ronald Smulders is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Urology. According to data from OpenAlex, Ronald Smulders has authored 36 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Endocrinology, Diabetes and Metabolism, 8 papers in Molecular Biology and 8 papers in Urology. Recurrent topics in Ronald Smulders's work include Diabetes Treatment and Management (9 papers), Urinary Bladder and Prostate Research (8 papers) and Metabolism, Diabetes, and Cancer (6 papers). Ronald Smulders is often cited by papers focused on Diabetes Treatment and Management (9 papers), Urinary Bladder and Prostate Research (8 papers) and Metabolism, Diabetes, and Cancer (6 papers). Ronald Smulders collaborates with scholars based in Netherlands, United States and Japan. Ronald Smulders's co-authors include Walter Krauwinkel, Takeshi Kadokura, Stephan A. Veltkamp, Coen D.A. Stehouwer, Andreas Seidl, Hans Koll, Patrick Garidel, Bryan Smith, John den Engelsman and Stefan Bassarab and has published in prestigious journals such as Diabetes Care, Pharmaceutical Research and Vaccine.

In The Last Decade

Ronald Smulders

35 papers receiving 1.1k citations

Peers

Ronald Smulders
Akira Ueno Japan
Hyung‐Doo Park South Korea
Pankaj Wadhwa India
Robert A. Shalwitz United States
L. Lenti Italy
Wei Gong China
Shan Lin China
Cinzia Arcelloni Italy
Sándor Túri Hungary
Lei Gao China
Akira Ueno Japan
Ronald Smulders
Citations per year, relative to Ronald Smulders Ronald Smulders (= 1×) peers Akira Ueno

Countries citing papers authored by Ronald Smulders

Since Specialization
Citations

This map shows the geographic impact of Ronald Smulders's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ronald Smulders with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ronald Smulders more than expected).

Fields of papers citing papers by Ronald Smulders

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ronald Smulders. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ronald Smulders. The network helps show where Ronald Smulders may publish in the future.

Co-authorship network of co-authors of Ronald Smulders

This figure shows the co-authorship network connecting the top 25 collaborators of Ronald Smulders. A scholar is included among the top collaborators of Ronald Smulders based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ronald Smulders. Ronald Smulders is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Borys, Dorota, Richard Rupp, Ronald Smulders, et al.. (2024). Safety, tolerability and immunogenicity of a novel 24-valent pneumococcal vaccine in toddlers: A phase 1 randomized controlled trial. Vaccine. 42(10). 2560–2571. 8 indexed citations
3.
Ferslew, Brian C., Ronald Smulders, Tong Zhu, et al.. (2023). Safety and immunopharmacology of ASP0892 in adults or adolescents with peanut allergy: two randomized trials. Allergy. 79(2). 456–470. 5 indexed citations
4.
5.
Watt, Fiona E., et al.. (2019). Tropomyosin-related kinase A (TrkA) inhibition for the treatment of painful knee osteoarthritis: results from a randomized controlled phase 2a trial. Osteoarthritis and Cartilage. 27(11). 1590–1598. 27 indexed citations
6.
Kadokura, Takeshi, Wenhui Zhang, Walter Krauwinkel, et al.. (2014). Clinical Pharmacokinetics and Pharmacodynamics of the Novel SGLT2 Inhibitor Ipragliflozin. Clinical Pharmacokinetics. 53(11). 975–988. 27 indexed citations
7.
Zhang, Wenhui, Walter Krauwinkel, James J. Keirns, et al.. (2013). The Effect of Moderate Hepatic Impairment on the Pharmacokinetics of Ipragliflozin, a Novel Sodium Glucose Co-Transporter 2 (SGLT2) Inhibitor. Clinical Drug Investigation. 33(7). 489–496. 24 indexed citations
8.
Veltkamp, Stephan A., et al.. (2012). Combination Treatment With Ipragliflozin and Metformin: A Randomized, Double-Blind, Placebo-Controlled Study in Patients With Type 2 Diabetes Mellitus. Clinical Therapeutics. 34(8). 1761–1771. 21 indexed citations
9.
Veltkamp, Stephan A., Takeshi Kadokura, Walter Krauwinkel, & Ronald Smulders. (2011). Effect of Ipragliflozin (ASP1941), a Novel Selective Sodium-Dependent Glucose Co-Transporter 2 Inhibitor, on Urinary Glucose Excretion in Healthy Subjects. Clinical Drug Investigation. 31(12). 839–851. 52 indexed citations
10.
Engelsman, John den, Patrick Garidel, Ronald Smulders, et al.. (2010). Strategies for the Assessment of Protein Aggregates in Pharmaceutical Biotech Product Development. Pharmaceutical Research. 28(4). 920–933. 290 indexed citations
11.
Smulders, Ronald, et al.. (2007). Pharmacokinetics, Safety, and Tolerability of Solifenacin in Patients With Renal Insufficiency. Journal of Pharmacological Sciences. 103(1). 67–74. 21 indexed citations
12.
Smulders, Ronald, Mirjam Kuipers, & Walter Krauwinkel. (2006). Multiple doses of the antimuscarinic agent solifenacin do not affect the pharmacodynamics or pharmacokinetics of warfarin or the steady‐state pharmacokinetics of digoxin in healthy subjects. British Journal of Clinical Pharmacology. 62(2). 210–217. 9 indexed citations
13.
Swart, Pieter, Walter Krauwinkel, Ronald Smulders, & Neila Smith. (2006). Pharmacokinetic Effect of Ketoconazole on Solifenacin in Healthy Volunteers. Basic & Clinical Pharmacology & Toxicology. 99(1). 33–36. 21 indexed citations
14.
Kuipers, Mirjam, et al.. (2006). Open-Label Study of the Safety and Pharmacokinetics of Solifenacin in Subjects With Hepatic Impairment. Journal of Pharmacological Sciences. 102(4). 405–412. 17 indexed citations
15.
16.
Krauwinkel, Walter, et al.. (2005). Effect of age on the pharmacokinetics of solifenacin in men and women. International Journal of Clinical Pharmacology and Therapeutics. 43(5). 227–238. 33 indexed citations
17.
Smulders, Ronald, Walter Krauwinkel, Pieter Swart, & Moses Huang. (2004). Pharmacokinetics and Safety of Solifenacin Succinate in Healthy Young Men. The Journal of Clinical Pharmacology. 44(9). 1023–1033. 52 indexed citations
18.
Uchida, Taisuke, Walter Krauwinkel, Hans Mulder, & Ronald Smulders. (2004). Food does not affect the pharmacokinetics of solifenacin, a new muscarinic receptor antagonist: results of a randomized crossover trial. British Journal of Clinical Pharmacology. 58(1). 4–7. 22 indexed citations
19.
Schalkwijk, Casper G., Ronald Smulders, J Lambert, A. J. M. Donker, & Coen D.A. Stehouwer. (2000). ACE‐inhibition modulates some endothelial functions in healthy subjects and in normotensive type 1 diabetic patients. European Journal of Clinical Investigation. 30(10). 853–860. 33 indexed citations
20.
Lambert, J, et al.. (1997). The acute effect of hyperglycaemia on vessel wall properties. Scandinavian Journal of Clinical and Laboratory Investigation. 57(5). 409–414. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Akira Ueno Breakdown of academic impact, for papers by Hyung‐Doo Park Breakdown of academic impact, for papers by Pankaj Wadhwa Breakdown of academic impact, for papers by Robert A. Shalwitz Breakdown of academic impact, for papers by L. Lenti Breakdown of academic impact, for papers by Wei Gong Breakdown of academic impact, for papers by Shan Lin Breakdown of academic impact, for papers by Cinzia Arcelloni Breakdown of academic impact, for papers by Sándor Túri Breakdown of academic impact, for papers by Lei Gao
Rankless by CCL
2026